MENU
Showcases Stock ranks Forex

Strata Skin Scien (SSKN)
0.3945  -0.051 (-11.35%) 03-28 12:14
Open: 0.44 Pre. Close: 0.445
High: 0.4401 Low: 0.38
Volume: 88,295 Market Cap: 14(M)
Stock Technical Analysis
Overall:     
Target: Six months: 0.60
One year: 0.70
Support: Support1: 0.38
Support2: 0.32
Resistance: Resistance1: 0.52
Resistance2: 0.60
Pivot: 0.49
Moving Averages: MA(5): 0.46
MA(20): 0.50
MA(100): 0.51
MA(250): 0.70
MACD: MACD(12,26): -0.02
Signal(12,26,9): -0.01
%K %D: %K(14,3): 2.54
%D(3): 7.00
RSI: RSI(14): 25.34
52-Week: High: 1.15
Low: 0.26
Change(%): -65.8
Average Vol(K): 3-Month: 24
10-Days: 31
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 0.491 - 0.495 0.495 - 0.497
Low: 0.432 - 0.436 0.436 - 0.439
Close: 0.435 - 0.441 0.441 - 0.445
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.

[ SSKN ] has closed below the lower bollinger band by 18.7%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ SSKN ] is to continue within current trading range. Bollinger Bands are 2.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Stock chart
Stock News
Wed, 27 Mar 2024
STRATA Skin Sciences earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa

Wed, 27 Mar 2024
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q4 2023 - InvestorPlace

Wed, 27 Mar 2024
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript - Seeking Alpha

Wed, 27 Mar 2024
STRATA Skin Sciences Third Quarter 2022 Earnings: Beats Expectations - Yahoo Movies Canada

Wed, 27 Mar 2024
STRATA Skin Sciences Unveils Annual Financial Results - TipRanks.com - TipRanks

Wed, 27 Mar 2024
STRATA Skin Sciences Inc reports results for the quarter ended in December - Earnings Summary - TradingView

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Medical - Devices
Shares Out. (M) 35.05
Shares Float (M) 11.93
% Held by Insiders 4.27
% Held by Institutions 66.99
Shares Short (K) 223
Shares Short Prior Month (K) 223
Stock Financials
EPS -0.200
Book Value (p.s.) 0.460
Profit Margin -20.40
Operating Margin -6.95
Return on Assets (ttm) -6.3
Return on Equity (ttm) -37.9
Qtrly Rev. Growth -6.0
Gross Profit (p.s.)
Sales Per Share 1.006
EBITDA (p.s.) 0.016
Qtrly Earnings Growth
Operating Cash Flow (M) -2.03
Levered Free Cash Flow (M) -4.29
Stock Valuation
PE Ratio -1.95
PEG Ratio -0.10
Price to Book value 0.85
Price to Sales 0.39
Price to Cash Flow -6.73
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android